Predicted protein targets (top 10)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | KCNH2 | Q12809 | 4/20 | 0.52 |
| ▸ | MTNR1A | P48039 | 3/20 | 0.50 |
| ▸ | MTNR1B | P49286 | 3/20 | 0.50 |
| ▸ | KDM4E | B2RXH2 | 2/20 | 0.42 |
| ▸ | SIGMAR1 | Q99720 | 1/20 | 0.41 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.41 |
| ▸ | TAAR1 | Q96RJ0 | 1/20 | 0.40 |
| ▸ | NPSR1 | Q6W5P4 | 1/20 | 0.39 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.39 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.39 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL10425499 | 0.97 | KCNH2 (0.50) | KCNH2MTNR1AMTNR1BKDM4ESIGMAR1 | |
| SCHEMBL28613602 | 0.89 | KCNH2 (0.45) | KCNH2MTNR1AMTNR1BKDM4ESIGMAR1 | |
| SCHEMBL4970515 | 0.88 | KCNH2 (0.50) | KCNH2MTNR1AMTNR1BSIGMAR1 | |
| SCHEMBL138431 | 0.88 | KCNH2 (0.50) | KCNH2MTNR1AMTNR1BKDM4ESIGMAR1 | |
| SCHEMBL10707846 | 0.87 | MTNR1A (0.47) | KCNH2MTNR1AMTNR1BKDM4ESIGMAR1 | |
| SCHEMBL6441273 | 0.85 | KCNH2 (0.47) | KCNH2MTNR1AMTNR1BKDM4ESIGMAR1 | |
| SCHEMBL10830280 | 0.85 | KCNH2 (0.48) | KCNH2MTNR1AMTNR1BSIGMAR1 | |
| SCHEMBL4194250 | 0.85 | KCNH2 (0.48) | KCNH2MTNR1AMTNR1BSIGMAR1 | |
| SCHEMBL18979892 | 0.84 | CYP3A4 (0.62) | KCNH2MTNR1AMTNR1BKDM4EL3MBTL1 | |
| SCHEMBL158097 | 0.83 | MTNR1A (0.48) | KCNH2MTNR1AMTNR1BKDM4ESIGMAR1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 51 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-119608075-A | Industrial trimethylolpropane continuous production method and system thereof | 天津海成能源工程技术有限公司 | 2025-03-14 | — | — | CN | claimed |
| CN-118388402-A | Continuous preparation method of 3-cyano-4-trifluoromethyl pyridine | 山东京博生物科技有限公司 | 2024-07-26 | — | — | CN | claimed |
| EP-0099924-B1 | IMMUNOLOGIC ASSAY FOR DETERMINING PRESENCE OF A PHOSPHOLIPID IN BIOLOGICAL FLUID | HANA BIOLOGICS, INC. (US) | 1986-05-07 | — | — | EP | claimed |
| US-4481373-A | CATALYTIC OXIDATION OF OLEFINS IN PRESENCE OF TERTIARY AMINE OF AMIDE | TOA NENRYO KOGYO KABUSHIKI KAISHA (JP) | 1984-11-06 | — | — | US | claimed |
| WO-2026104818-A1 | COMPLEX | JOHNSON MATTHEY PUBLIC LIMITED COMPANY (GB) | 2026-05-21 | — | — | WO | disclosed |
| CN-119608075-A | Industrial trimethylolpropane continuous production method and system thereof | 天津海成能源工程技术有限公司 | 2025-03-14 | — | — | CN | disclosed |
| CN-118388402-A | Continuous preparation method of 3-cyano-4-trifluoromethyl pyridine | 山东京博生物科技有限公司 | 2024-07-26 | — | — | CN | disclosed |
| US-20240228682-A1 | POLYETHYLENE COPOLYMER WITH BROAD SHORT CHAIN BRANCHING DISTRIBUTION | W.R. GRACE & CO.-CONN. (US) | 2024-07-11 | — | — | US | disclosed |
| EP-4337703-A1 | POLYETHYLENE COPOLYMER WITH BROAD SHORT CHAIN BRANCHING DISTRIBUTION | W. R. Grace & Co.-Conn (US) | 2024-03-20 | — | — | EP | disclosed |
| WO-2023166948-A1 | (METH)ACRYLATE-TERMINATED POLYPHENYLENE ETHER OLIGOMER, AND RESIN COMPOSITION, VARNISH, PREPREG, AND CURED PRODUCT CONTAINING SAME | 本州化学工業株式会社 | 2023-09-07 | — | — | WO | disclosed |
| US-11691136-B2 | Olefin oligomerization catalyst and method for producing olefin oligomer in the presence of the same catalyst | MITSUI CHEMICALS, INC. (JP) | 2023-07-04 | — | — | US | disclosed |
| US-11691136-B2 | Olefin oligomerization catalyst and method for producing olefin oligomer in the presence of the same catalyst | MITSUI CHEMICALS, INC. (JP) | 2023-07-04 | — | — | US | disclosed |
| EP-0086281-B1 | PREPARATION OF CARBAMATES USING A PALLADIUM-CONTAINING CATALYST | SHELL INTERNATIONALE RESEARCHMAATSCHAPPIJ B.V. (NL) | 1985-05-15 | — | — | EP | disclosed |
| US-4503140-A | Radiation-sensitive compositions of polymers containing a π-metal carbonyl complex of conjugated polyolefin | MINNESOTA MINING AND MANUFACTURING COMPANY (US) | 1985-03-05 | — | — | US | disclosed |
| US-4481373-A | CATALYTIC OXIDATION OF OLEFINS IN PRESENCE OF TERTIARY AMINE OF AMIDE | TOA NENRYO KOGYO KABUSHIKI KAISHA (JP) | 1984-11-06 | — | — | US | disclosed |
| US-4474978-A | Preparation of carbamates | SHELL OIL COMPANY (US) | 1984-10-02 | — | — | US | disclosed |
| EP-0095269-A2 | Radiation-sensitive compositions of polymers containing a pi-metal carbonyl complex of conjugated polyolefin | MINNESOTA MINING AND MANUFACTURING COMPANY (US) | 1983-11-30 | — | — | EP | disclosed |
| EP-0068866-A1 | Method of manufacturing acetone or methyl ethyl ketone | TOA NENRYO KOGYO KABUSHIKI KAISHA (JP) | 1983-01-05 | — | — | EP | disclosed |
| US-4095022-A | PHOSPHORUS COMPOUNDS, SILICA-ALUMINA CATALYST | TEXACO DEVELOPMENT CORPORATION (US) | 1978-06-13 | — | — | US | disclosed |
| US-4026935-A | FROM N-(HYDROXYALKYL)-MORPHOLINE COMPOUND, SILICA-ALUMINA CATALYST | TEXACO DEVELOPMENT CORPORATION (US) | 1977-05-31 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-11691136-B2 | Olefin oligomerization catalyst and method for producing olefin oligomer in the presence of the same catalyst | OXER1, COG6, CBR1 | KCNH2 2468/4885MTNR1A 1946/4885MTNR1B 1860/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.